NCT04490031View on ClinicalTrials.gov

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

PHASE4RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 31, 2020

Study Completion Date

April 30, 2021

Conditions
Ketamine Adverse Reaction
Interventions
DRUG

Ketamine Hydrochloride

patient in Ketamine group will be given Ketamine as sedative agent

Trial Locations (1)

56000

RECRUITING

University Kebangsaan Malaysia Medical center, Bandar Tun Razak

All Listed Sponsors
lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER